Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardiac Safety of Dihydroartemisinin-Piperaquine in Pregnant Women
NCT02909712Phase 2Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Sep 2016
- Primary completion
- Jan 2020
- Modality
- Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of dihydroartemisinin + piperaquine in malaria, sponsored by London School of Hygiene & Tropical Medicine. Started Sep 2016; status: completed.
02
Drugs
dihydroartemisinin + piperaquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT02909712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02909712.